FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:FMS • US3580291066

24.08 USD
-0.27 (-1.11%)
At close: Feb 6, 2026
24.08 USD
0 (0%)
After Hours: 2/6/2026, 4:15:00 PM
Fundamental Rating

5

FMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. FMS has an average financial health and profitability rating. FMS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year FMS was profitable.
  • In the past year FMS had a positive cash flow from operations.
  • Each year in the past 5 years FMS has been profitable.
  • Each year in the past 5 years FMS had a positive operating cash flow.
FMS Yearly Net Income VS EBIT VS OCF VS FCFFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • FMS has a Return On Assets of 2.33%. This is comparable to the rest of the industry: FMS outperforms 58.82% of its industry peers.
  • FMS has a Return On Equity of 5.55%. This is in the better half of the industry: FMS outperforms 60.78% of its industry peers.
  • FMS's Return On Invested Capital of 3.95% is in line compared to the rest of the industry. FMS outperforms 50.00% of its industry peers.
  • FMS had an Average Return On Invested Capital over the past 3 years of 3.14%. This is significantly below the industry average of 9.16%.
  • The 3 year average ROIC (3.14%) for FMS is below the current ROIC(3.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROIC 3.95%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
FMS Yearly ROA, ROE, ROICFMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of FMS (3.66%) is better than 73.53% of its industry peers.
  • FMS's Profit Margin has declined in the last couple of years.
  • FMS has a Operating Margin of 7.19%. This is in the better half of the industry: FMS outperforms 72.55% of its industry peers.
  • FMS's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 25.00%, FMS is in line with its industry, outperforming 51.96% of the companies in the same industry.
  • In the last couple of years the Gross Margin of FMS has declined.
Industry RankSector Rank
OM 7.19%
PM (TTM) 3.66%
GM 25%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
FMS Yearly Profit, Operating, Gross MarginsFMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • FMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, FMS has about the same amount of shares outstanding.
  • FMS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for FMS has been reduced compared to a year ago.
FMS Yearly Shares OutstandingFMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
FMS Yearly Total Debt VS Total AssetsFMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • FMS has an Altman-Z score of 1.81. This is a bad value and indicates that FMS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.81, FMS is in line with its industry, outperforming 48.04% of the companies in the same industry.
  • FMS has a debt to FCF ratio of 5.97. This is a neutral value as FMS would need 5.97 years to pay back of all of its debts.
  • FMS has a Debt to FCF ratio of 5.97. This is in the better half of the industry: FMS outperforms 62.75% of its industry peers.
  • FMS has a Debt/Equity ratio of 0.73. This is a neutral value indicating FMS is somewhat dependend on debt financing.
  • FMS has a Debt to Equity ratio (0.73) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Altman-Z 1.81
ROIC/WACC0.77
WACC5.16%
FMS Yearly LT Debt VS Equity VS FCFFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that FMS should not have too much problems paying its short term obligations.
  • The Current ratio of FMS (1.36) is comparable to the rest of the industry.
  • FMS has a Quick Ratio of 1.36. This is a bad value and indicates that FMS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.00, FMS is doing worse than 65.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
FMS Yearly Current Assets VS Current LiabilitesFMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.77% over the past year.
  • Measured over the past years, FMS shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
  • FMS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
  • FMS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%

3.2 Future

  • Based on estimates for the next years, FMS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.37% on average per year.
  • The Revenue is expected to grow by 3.81% on average over the next years.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FMS Yearly Revenue VS EstimatesFMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FMS Yearly EPS VS EstimatesFMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.90 indicates a reasonable valuation of FMS.
  • 88.24% of the companies in the same industry are more expensive than FMS, based on the Price/Earnings ratio.
  • FMS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.67.
  • The Price/Forward Earnings ratio is 9.89, which indicates a very decent valuation of FMS.
  • Based on the Price/Forward Earnings ratio, FMS is valued cheaply inside the industry as 90.20% of the companies are valued more expensively.
  • FMS is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.9
Fwd PE 9.89
FMS Price Earnings VS Forward Price EarningsFMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, FMS is valued cheaper than 87.25% of the companies in the same industry.
  • FMS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FMS is cheaper than 90.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.83
EV/EBITDA 6.68
FMS Per share dataFMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • FMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • FMS's earnings are expected to grow with 13.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.85%, FMS has a reasonable but not impressive dividend return.
  • FMS's Dividend Yield is rather good when compared to the industry average which is at 0.48. FMS pays more dividend than 98.04% of the companies in the same industry.
  • FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.85%

5.2 History

  • The dividend of FMS has a limited annual growth rate of 0.31%.
  • FMS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of FMS decreased in the last 3 years.
Dividend Growth(5Y)0.31%
Div Incr Years2
Div Non Decr Years2
FMS Yearly Dividends per shareFMS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • FMS pays out 58.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of FMS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
FMS Yearly Income VS Free CF VS DividendFMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
FMS Dividend Payout.FMS Dividend Payout, showing the Payout Ratio.FMS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FRESENIUS MEDICAL CARE-ADR

NYSE:FMS (2/6/2026, 4:15:00 PM)

After market: 24.08 0 (0%)

24.08

-0.27 (-1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners43.91%
Inst Owner Change-0.31%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.13B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.86
Price Target27.89 (15.82%)
Short Float %0.55%
Short Ratio4.14
Dividend
Industry RankSector Rank
Dividend Yield 3.85%
Yearly Dividend0.71
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)0.55%
PT rev (3m)-3.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.21%
EPS NY rev (1m)0%
EPS NY rev (3m)2.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 10.9
Fwd PE 9.89
P/S 0.61
P/FCF 6.83
P/OCF 4.77
P/B 0.92
P/tB N/A
EV/EBITDA 6.68
EPS(TTM)2.21
EY9.18%
EPS(NY)2.44
Fwd EY10.11%
FCF(TTM)3.53
FCFY14.65%
OCF(TTM)5.05
OCFY20.96%
SpS39.49
BVpS26.03
TBVpS-3.79
PEG (NY)0.5
PEG (5Y)N/A
Graham Number35.98
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROCE 5.62%
ROIC 3.95%
ROICexc 4.26%
ROICexgc 11.65%
OM 7.19%
PM (TTM) 3.66%
GM 25%
FCFM 8.93%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Debt/EBITDA 3.12
Cap/Depr 47.15%
Cap/Sales 3.85%
Interest Coverage 3.87
Cash Conversion 83.24%
Profit Quality 244.33%
Current Ratio 1.36
Quick Ratio 1
Altman-Z 1.81
F-Score5
WACC5.16%
ROIC/WACC0.77
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.33%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%

FRESENIUS MEDICAL CARE-ADR / FMS FAQ

What is the fundamental rating for FMS stock?

ChartMill assigns a fundamental rating of 5 / 10 to FMS.


Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?

ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.


What is the profitability of FMS stock?

FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?

The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 21.73% in the next year.


Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?

The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 58.83%.